Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 1 , Pages 67-69 , January 2007

News in HIV Prevention: Microbicides

References 

  1. Alliance for Microbicide Development. (2006). Microbicide development strategy. (2006). Retrieved September 20, 2006, from http://www.microbicide.org
  2. Gates B., & Gates M. (2006, August). XVI International AIDS Conference keynote speech. Speech presented at the XIV International AIDS Conference, Toronto, Ontario, Canada.
  3. Global Campaign for Microbicides. (2002a). About microbicides. Retrieved September 20, 2006, from http://www.global-campaign.org/clinical_testing.htm
  4. Global Campaign for Microbicides. (2002b). Clinical testing. Retrieved September 20, 2006, from http://www.global-campaign.org/clinical_testing.htm
  5. Lewis S. (2006, August). Closing session: Keynote Address. Speech presented at the XIV International AIDS Conference, Toronto, Ontario, Canada.
  6. Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, et al. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006;20:543–551
  7. Ramjee G. (2006, August). Microbicides and other prevention techniques. XVI International AIDS Conference, Toronto, Ontario, Canada.
  8. Rockefeller Foundation. The science of microbicides: Accelerating development. New York, NY: Author; 2002;
  9. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368:489–504
  10. Stone A, Jiang S. Microbicides: Stopping HIV at the gate. Lancet. 2006;368:431–433
  11. Voelker R. Anti-HIV Microbicide efforts press on. Medical News and Perspectives. 2006;296:753–755

PII: S1055-3290(06)00321-9

doi: 10.1016/j.jana.2006.11.014

Journal of the Association of Nurses in AIDS Care
Volume 18, Issue 1 , Pages 67-69 , January 2007